Priming mobilized peripheral blood mononuclear cells with the "activated platelet supernatant" enhances the efficacy of cell therapy for myocardial infarction of rats.

PubWeight™: 0.76^‹?›

🔗 View Article (PMID 27214098)

Published in Cardiovasc Ther on August 01, 2016

Authors

Jeehoon Kang¹^,2^,3, Jin Hur¹^,2^,4, Jin-A Kang²^,3, Hak Seung Lee¹^,2^,3, Heewon Jung²^,4, Jae-Il Choi²^,3, Hwan Lee²^,3, Yong Sook Kim⁵, Youngkeun Ahn⁵, Hyo-Soo Kim¹^,2^,3^,4

Author Affiliations

1: Department of Internal Medicine and Cardiovascular Center, Seoul National University Hospital, Seoul, Korea.
2: National Research Laboratory for Stem Cell Niche, Seoul National University College of Medicine, Seoul, Korea.
3: Molecular Medicine and Biopharmaceutical Sciences, Seoul National University, Seoul, Korea.
4: Innovative Research Institute for Cell Therapy, Seoul National University Hospital, Seoul, Korea.
5: Department of Cardiology, Chonnam National University Hospital, Gwangju, Korea.

Articles citing this ↘

Strategy to Prime the Host and Cells to Augment Therapeutic Efficacy of Progenitor Cells for Patients with Myocardial Infarction. Front Cardiovasc Med (2016) 0.75

Stem Cell Therapy for the Heart: Blind Alley or Magic Bullet? J Cardiovasc Transl Res (2016) 0.75

Articles by these authors ⇆

Genistein promotes endothelial colony-forming cell (ECFC) bioactivities and cardiac regeneration in myocardial infarction. PLoS One (2014) 0.80

The microRNA miR-124 inhibits vascular smooth muscle cell proliferation by targeting S100 calcium-binding protein A4 (S100A4). FEBS Lett (2017) 0.76

Pheochromocytoma as a rare hidden cause of inverted stress cardiomyopathy. J Cardiovasc Ultrasound (2014) 0.75

Tauroursodeoxycholic acid (TUDCA) attenuates pressure overload-induced cardiac remodeling by reducing endoplasmic reticulum stress. PLoS One (2017) 0.75